HealthEquity (NASDAQ:HQY) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.

Posted by Brenda Bartman on Jul 4th, 2026

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of HealthEquity, Inc. (NASDAQ:HQY). In a filing disclosed on July 02nd, the Representative disclosed that they had bought between $1,001 and $15,000 in HealthEquity stock on June 30th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of The Descartes Systems Group (NASDAQ:DSGX) on 6/30/2026.
Purchased $1,001 – $15,000 in shares of Texas Roadhouse (NASDAQ:TXRH) on 6/30/2026.
Purchased $1,001 – $15,000 in shares of Texas Capital Bancshares (NASDAQ:TCBI) on 6/30/2026.
Sold $1,001 – $15,000 in shares of SoftBank Group (OTCMKTS:SFTBF) on 6/30/2026.
Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 6/30/2026.
Sold $1,001 – $15,000 in shares of RBC Bearings (NYSE:RBC) on 6/30/2026.
Purchased $1,001 – $15,000 in shares of Microchip Technology (NASDAQ:MCHP) on 6/30/2026.
Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 6/30/2026.
Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 6/30/2026.
Purchased $1,001 – $15,000 in shares of CECO Environmental (NASDAQ:CECO) on 6/30/2026.

HealthEquity Price Performance

Shares of HQY stock remained flat at $95.31 during trading on Friday. The company had a trading volume of 986,248 shares, compared to its average volume of 993,550. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $105.96. The business has a fifty day moving average price of $86.04 and a two-hundred day moving average price of $84.67. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The stock has a market capitalization of $7.97 billion, a PE ratio of 35.70, a PEG ratio of 1.60 and a beta of 0.21.

HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HQY. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Citizens Jmp upped their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Wells Fargo & Company set a $111.00 price objective on HealthEquity in a research report on Monday, June 1st. Finally, Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

View Our Latest Analysis on HealthEquity

Hedge Funds Weigh In On HealthEquity

Several hedge funds have recently bought and sold shares of the company. William Blair Investment Management LLC bought a new position in HealthEquity in the fourth quarter valued at approximately $169,956,000. Norges Bank bought a new position in HealthEquity in the fourth quarter valued at about $66,927,000. AQR Capital Management LLC lifted its holdings in shares of HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after acquiring an additional 661,795 shares during the last quarter. Wasatch Advisors LP grew its holdings in shares of HealthEquity by 9.3% during the 1st quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock valued at $601,949,000 after purchasing an additional 613,288 shares during the last quarter. Finally, Millennium Management LLC increased its position in HealthEquity by 151.5% during the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after purchasing an additional 573,283 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the sale, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 13,081 shares of company stock valued at $1,193,000 in the last quarter. Insiders own 1.60% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About HealthEquity

(Get Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.